KM Biologics Overview
- Status
-
Acquired/Merged
- Employees
-
2,032
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
KM Biologics General Information
Description
Manufacturer of biological products for disease prevention and treatment. The company produces vaccines, antitoxins, antivenoms, blood plasma products, and veterinary vaccines, enabling healthcare providers and veterinarians to prevent and treat diseases, ultimately contributing to improved life sciences and public health outcomes worldwide.
Contact Information
Website
www.kmbiologics.com(Operating Subsidiary)
Corporate Office
- 1-6-1 Okubo, Kita-ku
- Kumamoto-shi
- Kumamoto, 860-8568
- Japan
Corporate Office
- 1-6-1 Okubo, Kita-ku
- Kumamoto-shi
- Kumamoto, 860-8568
- Japan
KM Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Merger/Acquisition | 02-Jul-2018 | Completed | Generating Revenue |
KM Biologics Patents
KM Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7883079-B1 | Method for thawing frozen plasma, and method for producing plasma-derived products and blood coagulation factor viii products. | Active | 16-Feb-2026 | ||
| JP-7910205-B1 | Method for producing a concentrated solution of attenuated swine parvovirus | Active | 09-Sep-2025 | ||
| JP-7936444-B1 | Method for preparing sars-cov-2 virus samples | Active | 03-Sep-2025 | ||
| JP-7866129-B1 | Method for evaluating the hardness of virus particles and method for early detection of changes in the properties of antigen particles | Active | 27-Aug-2025 | ||
| WO-2026225638-A1 | Pharmaceutical composition including blood coagulation factor x used in combination with compound for suppressing expression or activity of blood coagulation inhibitor | Pending | 25-Apr-2025 |
KM Biologics Signals
KM Biologics FAQs
-
Where is KM Biologics headquartered?
KM Biologics is headquartered in Kumamoto, Japan.
-
What is the size of KM Biologics?
KM Biologics has 2,032 total employees.
-
What industry is KM Biologics in?
KM Biologics’s primary industry is Pharmaceuticals.
-
Is KM Biologics a private or public company?
KM Biologics is a Private company.
-
What is KM Biologics’s current revenue?
The current revenue for KM Biologics is .
-
When was KM Biologics acquired?
KM Biologics was acquired on 01-Jan-2022.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process